56 related articles for article (PubMed ID: 31205101)
21. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Sahin U; Derhovanessian E; Miller M; Kloke BP; Simon P; Löwer M; Bukur V; Tadmor AD; Luxemburger U; Schrörs B; Omokoko T; Vormehr M; Albrecht C; Paruzynski A; Kuhn AN; Buck J; Heesch S; Schreeb KH; Müller F; Ortseifer I; Vogler I; Godehardt E; Attig S; Rae R; Breitkreuz A; Tolliver C; Suchan M; Martic G; Hohberger A; Sorn P; Diekmann J; Ciesla J; Waksmann O; Brück AK; Witt M; Zillgen M; Rothermel A; Kasemann B; Langer D; Bolte S; Diken M; Kreiter S; Nemecek R; Gebhardt C; Grabbe S; Höller C; Utikal J; Huber C; Loquai C; Türeci Ö
Nature; 2017 Jul; 547(7662):222-226. PubMed ID: 28678784
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope.
Lehman JM; Gwin ME; Massion PP
Curr Oncol Rep; 2017 Jul; 19(7):49. PubMed ID: 28643173
[TBL] [Abstract][Full Text] [Related]
23. Unus pro omnibus, omnes pro uno: A novel, evidence-based, unifying theory for the pathogenesis of endometriosis.
Laganà AS; Vitale SG; Salmeri FM; Triolo O; Ban Frangež H; Vrtačnik-Bokal E; Stojanovska L; Apostolopoulos V; Granese R; Sofo V
Med Hypotheses; 2017 Jun; 103():10-20. PubMed ID: 28571791
[TBL] [Abstract][Full Text] [Related]
24. Aging-related changes in human T-cell repertoire over 20years delineated by deep sequencing of peripheral T-cell receptors.
Yoshida K; Cologne JB; Cordova K; Misumi M; Yamaoka M; Kyoizumi S; Hayashi T; Robins H; Kusunoki Y
Exp Gerontol; 2017 Oct; 96():29-37. PubMed ID: 28535950
[TBL] [Abstract][Full Text] [Related]
25. Targeting neoantigens to augment antitumour immunity.
Yarchoan M; Johnson BA; Lutz ER; Laheru DA; Jaffee EM
Nat Rev Cancer; 2017 Apr; 17(4):209-222. PubMed ID: 28233802
[TBL] [Abstract][Full Text] [Related]
26. Applications of Immunogenomics to Cancer.
Liu XS; Mardis ER
Cell; 2017 Feb; 168(4):600-612. PubMed ID: 28187283
[TBL] [Abstract][Full Text] [Related]
27. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
Brown CE; Alizadeh D; Starr R; Weng L; Wagner JR; Naranjo A; Ostberg JR; Blanchard MS; Kilpatrick J; Simpson J; Kurien A; Priceman SJ; Wang X; Harshbarger TL; D'Apuzzo M; Ressler JA; Jensen MC; Barish ME; Chen M; Portnow J; Forman SJ; Badie B
N Engl J Med; 2016 Dec; 375(26):2561-9. PubMed ID: 28029927
[TBL] [Abstract][Full Text] [Related]
28. Advances in Cancer Immunotherapy in Solid Tumors.
Menon S; Shin S; Dy G
Cancers (Basel); 2016 Nov; 8(12):. PubMed ID: 27886124
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of γ-secretase activity synergistically enhances tumour necrosis factor-related apoptosis-inducing ligand induced apoptosis in T-cell acute lymphoblastic leukemia cells via upregulation of death receptor 5.
Greene LM; Nathwani SM; Zisterer DM
Oncol Lett; 2016 Oct; 12(4):2900-2905. PubMed ID: 27698877
[TBL] [Abstract][Full Text] [Related]
30. Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives.
Vetvicka V; Laganà AS; Salmeri FM; Triolo O; Palmara VI; Vitale SG; Sofo V; Králíčková M
Arch Gynecol Obstet; 2016 Nov; 294(5):897-904. PubMed ID: 27628753
[TBL] [Abstract][Full Text] [Related]
31. Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-cell Receptor Gene Therapy.
Hinrichs CS
Clin Cancer Res; 2016 Apr; 22(7):1559-64. PubMed ID: 27037253
[TBL] [Abstract][Full Text] [Related]
32. CGCG clinical practice guidelines for the management of adult diffuse gliomas.
Jiang T; Mao Y; Ma W; Mao Q; You Y; Yang X; Jiang C; Kang C; Li X; Chen L; Qiu X; Wang W; Li W; Yao Y; Li S; Li S; Wu A; Sai K; Bai H; Li G; Chen B; Yao K; Wei X; Liu X; Zhang Z; Dai Y; Lv S; Wang L; Lin Z; Dong J; Xu G; Ma X; Cai J; Zhang W; Wang H; Chen L; Zhang C; Yang P; Yan W; Liu Z; Hu H; Chen J; Liu Y; Yang Y; Wang Z; Wang Z; Wang Y; You G; Han L; Bao Z; Liu Y; Wang Y; Fan X; Liu S; Liu X; Wang Y; Wang Q;
Cancer Lett; 2016 Jun; 375(2):263-273. PubMed ID: 26966000
[TBL] [Abstract][Full Text] [Related]
33. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Ostrom QT; Gittleman H; Fulop J; Liu M; Blanda R; Kromer C; Wolinsky Y; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2015 Oct; 17 Suppl 4(Suppl 4):iv1-iv62. PubMed ID: 26511214
[No Abstract] [Full Text] [Related]
34. Adoptive T-cell therapy for cancer: The era of engineered T cells.
Bonini C; Mondino A
Eur J Immunol; 2015 Sep; 45(9):2457-69. PubMed ID: 26202766
[TBL] [Abstract][Full Text] [Related]
35. Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy.
Murugaesu N; Wilson GA; Birkbak NJ; Watkins T; McGranahan N; Kumar S; Abbassi-Ghadi N; Salm M; Mitter R; Horswell S; Rowan A; Phillimore B; Biggs J; Begum S; Matthews N; Hochhauser D; Hanna GB; Swanton C
Cancer Discov; 2015 Aug; 5(8):821-831. PubMed ID: 26003801
[TBL] [Abstract][Full Text] [Related]
36. MiXCR: software for comprehensive adaptive immunity profiling.
Bolotin DA; Poslavsky S; Mitrophanov I; Shugay M; Mamedov IZ; Putintseva EV; Chudakov DM
Nat Methods; 2015 May; 12(5):380-1. PubMed ID: 25924071
[No Abstract] [Full Text] [Related]
37. Deconstructing the peptide-MHC specificity of T cell recognition.
Birnbaum ME; Mendoza JL; Sethi DK; Dong S; Glanville J; Dobbins J; Ozkan E; Davis MM; Wucherpfennig KW; Garcia KC
Cell; 2014 May; 157(5):1073-87. PubMed ID: 24855945
[TBL] [Abstract][Full Text] [Related]
38. Managing cytokine release syndrome associated with novel T cell-engaging therapies.
Maude SL; Barrett D; Teachey DT; Grupp SA
Cancer J; 2014; 20(2):119-22. PubMed ID: 24667956
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Davila ML; Riviere I; Wang X; Bartido S; Park J; Curran K; Chung SS; Stefanski J; Borquez-Ojeda O; Olszewska M; Qu J; Wasielewska T; He Q; Fink M; Shinglot H; Youssif M; Satter M; Wang Y; Hosey J; Quintanilla H; Halton E; Bernal Y; Bouhassira DC; Arcila ME; Gonen M; Roboz GJ; Maslak P; Douer D; Frattini MG; Giralt S; Sadelain M; Brentjens R
Sci Transl Med; 2014 Feb; 6(224):224ra25. PubMed ID: 24553386
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
Chinot OL; Wick W; Mason W; Henriksson R; Saran F; Nishikawa R; Carpentier AF; Hoang-Xuan K; Kavan P; Cernea D; Brandes AA; Hilton M; Abrey L; Cloughesy T
N Engl J Med; 2014 Feb; 370(8):709-22. PubMed ID: 24552318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
